DoW Autism Idea Development Award | HT942526ARPIDA

FAQs: DoW Autism Idea Development Award (FY26) - Autism Research Program (ARP)

What is the DoW Autism Idea Development Award?

The DoW Autism Idea Development Award is a fiscal year 2026 funding opportunity under the Autism Research Program (ARP). It is designed to advance bold, innovative autism research, with a clear emphasis on high-risk, high-reward ideas that could generate early, impactful findings and open new research directions or lead to major breakthroughs.

What is the main purpose of this funding opportunity?

The central goal is to accelerate progress toward better outcomes for Autistic individuals by supporting research that is ambitious and potentially field-changing. The award prioritizes projects that can produce meaningful data that moves the field forward, especially when the work is too novel, unconventional, or exploratory for more traditional funding routes.

What type of research is this award intended to support?

This mechanism is intended for innovative autism research that may be considered high-risk and high-reward. It is positioned for projects that are exploratory or unconventional but still have a strong scientific rationale and the potential to shift the field through early, important results.

How does the award define "high-risk, high-reward" in practice?

Based on the opportunity description, "high-risk, high-reward" refers to ideas that may be too novel for traditional funding pathways but could produce early findings significant enough to open new lines of research or lead to major advances. Reviewers are expected to weigh both creativity and the plausibility of meaningful impact.

Does my proposal need to align with specific Areas of Interest?

Applicants are strongly encouraged to align their proposals with one of the program's FY26 ARP Idea Development Award Areas of Interest. The opportunity emphasizes relevance and urgency, so clear alignment is an important part of how the project is framed for review.

What if my project does not directly match an identified Area of Interest?

If a project does not directly match an identified area, the application is expected to clearly justify why the work still addresses a critical problem, question, or unmet need in autism. In other words, the proposal should make a strong case that the work targets an important gap and could plausibly drive real advances.

What will reviewers likely be looking for in applications?

The description signals that reviewers will look for scientific creativity and innovation, along with a well-argued justification that the project addresses an important autism-related gap or unmet need. The application should also support the claim that the work can realistically generate meaningful data that moves the field forward.

Is there an option for two Principal Investigators (Partnering PI)?

Yes. The opportunity includes a Partnering Principal Investigator (PI) option. Under this structure, two investigators are both designated as PIs on a single project.

How is the Partnering PI option expected to work?

The two PIs are expected to collaborate in a synergistic way rather than simply dividing tasks. The partnership should be essential to the project's success, and the combined expertise should enable outcomes that would not be achievable through separate, individual efforts.

Is the Partnering PI option the same as adding a co-investigator?

No. The description distinguishes the Partnering PI structure from a standard collaboration model. The intent is not simply to add another collaborator, but to create a true two-PI partnership that elevates the scope and impact of the research through essential, integrated teamwork.

Who is offering this grant?

This is a discretionary grant opportunity offered by the Defense Health Agency Contracting Activity (DHACA).

What is the funding activity category for this opportunity?

The funding activity category is listed as science and technology and other research and development.

What is the CFDA number associated with this funding opportunity?

The associated CFDA number is 12.420.

What is the opportunity number?

The opportunity number is HT942526ARPIDA.

Who is eligible to apply?

Eligible applicants are listed as unrestricted, indicating that a broad range of applicant types may apply, subject to the full solicitation terms.

How many awards are expected?

The listing indicates an expectation of three awards.

What is the application deadline?

The original closing date is October 22, 2026.

Is there an award ceiling or maximum budget listed?

The award ceiling is not specified in the provided information. This typically means applicants should consult the full announcement for budget limits, period of performance, and any cost or spending constraints.

Where can applicants find details like budget limits and period of performance?

The provided information notes that key administrative details such as budget limits, period of performance, and cost constraints are typically found in the full solicitation. Applicants should consult the full announcement for those specifics.

What is the overall positioning of this award compared with traditional funding?

The award is positioned as a competitive mechanism for ambitious autism studies that may be too novel or exploratory for more traditional funding routes, but that can credibly argue both innovation and importance to pressing autism-related needs.